Search research articles
Contact Us
Filters
Showing results (21-30 of 999) with videos related to
Page
of 100
Sort By:
British Medical Journal
|
August 27, 2010
HYSTERECTOMY: A CRITICAL SURVEY
A H Davidson
Current Cardiology Reports
|
September 8, 2010
Should niacin be the preferred drug to add to a statin?
Michael H Davidson
Biochimica Et Biophysica Acta
|
December 6, 2008
Developmental biology at the systems level
Eric H Davidson
Journal of the American College of Cardiology
|
December 22, 2012
Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure?
Michael H Davidson
Postgraduate Medicine
|
August 12, 2009
Reducing cardiovascular risk: trends in risk, risk assessment, and cholesterol management
Michael H Davidson
The American Journal of Medicine
|
June 7, 2002
A look to the future: new treatment guidelines and a perspective on statins
Michael H Davidson,
Oecologia
|
March 18, 2017
Assimilation efficiencies of slugs on different food materials
D H Davidson
Regulatory Toxicology and Pharmacology : RTP
|
February 1, 1996
Food additive approvals: risks vs benefits
M H Davidson
The American Journal of Cardiology
|
October 16, 2012
Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist
Michael H Davidson
JAMA Internal Medicine
|
June 18, 2014
Waiting for words
John H Davidson
Page
of 100
Search research articles
Search
Showing results (21-30 of 999) with videos related to
Sort By:
Page
of 100
British Medical Journal
|
August 27, 2010
HYSTERECTOMY: A CRITICAL SURVEY
A H Davidson
Current Cardiology Reports
|
September 8, 2010
Should niacin be the preferred drug to add to a statin?
Michael H Davidson
Biochimica Et Biophysica Acta
|
December 6, 2008
Developmental biology at the systems level
Eric H Davidson
Journal of the American College of Cardiology
|
December 22, 2012
Low-density lipoprotein cholesterol, non-high-density lipoprotein, apolipoprotein, or low-density lipoprotein particle: what should clinicians measure?
Michael H Davidson
Postgraduate Medicine
|
August 12, 2009
Reducing cardiovascular risk: trends in risk, risk assessment, and cholesterol management
Michael H Davidson
The American Journal of Medicine
|
June 7, 2002
A look to the future: new treatment guidelines and a perspective on statins
Michael H Davidson,
Oecologia
|
March 18, 2017
Assimilation efficiencies of slugs on different food materials
D H Davidson
Regulatory Toxicology and Pharmacology : RTP
|
February 1, 1996
Food additive approvals: risks vs benefits
M H Davidson
The American Journal of Cardiology
|
October 16, 2012
Cardiovascular risk factors in a patient with diabetes mellitus and coronary artery disease: therapeutic approaches to improve outcomes: perspectives of a preventive cardiologist
Michael H Davidson
JAMA Internal Medicine
|
June 18, 2014
Waiting for words
John H Davidson
Page
of 100